The regenerative medicine market will grow from USD 48.45 Bn in 2024 to USD 403.86 Bn by 2032 at a 27.3% CAGR, supported by recent global investments.
FLORIDA, FL, UNITED STATES, July 30, 2025 /EINPresswire.com/ — Regenerative medicine encompassing cell therapy, gene therapy, stem cells, tissue engineering, and acellular biomaterials is revolutionizing the treatment of chronic and degenerative diseases. According to DataM Intelligence analysis, the global market size reached USD 48.45 billion in 2024 and is expected to hit USD 403.86 billion by 2032, growing at a 27.3% CAGR from 2025 to 2032. Rising chronic disease prevalence, clinical breakthroughs, and expanded reimbursement are enabling this rapid expansion.
